help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ABRAHAM, W. M.
Right arrow Articles by ELICES, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ABRAHAM, W. M.
Right arrow Articles by ELICES, M. J.

Am. J. Respir. Crit. Care Med., Volume 156, Number 3, September 1997, 696-703

Blockade of Late-phase Airway Responses and Airway Hyperresponsiveness in Allergic Sheep with a Small-molecule Peptide Inhibitor of VLA-4

WILLIAM M. ABRAHAM, ASHFAQ AHMED, MAREK W. SIELCZAK, MASAHIRO NARITA, THOMAS ARRHENIUS, and MARIANO J. ELICES

Division of Pulmonary Disease, Mount Sinai Medical Center, Miami Beach, Florida; and Cytel Corporation, San Diego, California

The leukocyte integrin very late antigen-4 (VLA-4) (alpha 4beta 1, CD49d/CD29) is an adhesion receptor predominantly expressed on lymphocytes, monocytes, and eosinophils, but not on neutrophils. Recent studies with monoclonal antibodies against VLA-4 suggest that antigen-induced late responses and airway hyperresponsiveness (AHR) may depend on the recruitment and/or activation of VLA-4-expressing leukocytes. To further test this hypothesis, we administered by aerosol either a potent small-molecule inhibitor of VLA-4, which prevents VLA-4-mediated binding to fibronectin (CS-1 ligand mimic), or an inactive control (30 mg twice daily for 3 d, and on the fourth day 0.5 h before and 4 h after antigen challenge) to six sheep with airway hypersensitivity to Ascaris suum antigen. Treatment with the small-molecule VLA-4 inhibitor resulted in a significant decrease in the early antigen-induced bronchial response (40%, p < 0.05), and almost complete blockade of the late-phase airway response (88%, p < 0.05). Moreover, at 24 h after antigen challenge, AHR to inhaled carbachol was not observed when the animals were dosed with the small-molecule VLA-4 inhibitor. In accord with protection against the functional abnormalities associated with antigen challenge, analysis of biopsy specimens taken 24 h after challenge indicated that the total numbers of VLA-4-positive cells (lymphocytes, eosinophils, and metachromatic-staining cells) in the group treated with the VLA-4 inhibitor did not increase, whereas these cells increased in the control group. The active agent, but not the inactive control, significantly blocked macrophage adherence to fibronectin (FN), indicating that the CS-1 ligand interfered with VLA-4-mediated adhesion in sheep cells. These results support our previous findings with a monoclonal antibody to VLA-4, and demonstrate that a small-molecule VLA-4 inhibitor, when given by aerosol, has a protective effect against antigen-induced late responses and AHR in allergic sheep.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
S. R. Barthel, M. W. Johansson, D. M. McNamee, and D. F. Mosher
Roles of integrin activation in eosinophil function and the eosinophilic inflammation of asthma
J. Leukoc. Biol., January 1, 2008; 83(1): 1 - 12.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. B. Pepinsky, W.-C. Lee, M. Cornebise, A. Gill, K. Wortham, L. L. Chen, D. R. Leone, K. Giza, B. M. Dolinski, S. Perper, et al.
Design, Synthesis, and Analysis of a Polyethelene Glycol-Modified (PEGylated) Small Molecule Inhibitor of Integrin {alpha}4{beta}1 with Improved Pharmaceutical Properties
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 742 - 750.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
D. R. Leone, K. Giza, A. Gill, B. M. Dolinski, W. Yang, S. Perper, D. M. Scott, W.-C. Lee, M. Cornebise, K. Wortham, et al.
An Assessment of the Mechanistic Differences Between Two Integrin {alpha}4{beta}1 Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune Encephalomyelitis
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1150 - 1162.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. Kudlacz, C. Whitney, C. Andresen, A. Duplantier, G. Beckius, L. Chupak, A. Klein, K. Kraus, and A. Milici
Pulmonary Eosinophilia in a Murine Model of Allergic Inflammation Is Attenuated by Small Molecule alpha 4beta 1 Antagonists
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 747 - 752.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. A. Boyce, E. A. Mellor, B. Perkins, Y.-C. Lim, and F. W. Luscinskas
Human mast cell progenitors use alpha 4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions
Blood, April 15, 2002; 99(8): 2890 - 2896.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
B. Beck-Schimmer, R. C. Schimmer, C. Madjdpour, J. M. Bonvini, T. Pasch, and P. A. Ward
Hypoxia Mediates Increased Neutrophil and Macrophage Adhesiveness to Alveolar Epithelial Cells
Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 780 - 787.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. T. Borchers, J. Crosby, S. Farmer, J. Sypek, T. Ansay, N. A. Lee, and J. J. Lee
Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L813 - L821.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
R. Kronenwett, S. Martin, and R. Haas
The Role of Cytokines and Adhesion Molecules for Mobilization of Peripheral Blood Stem Cells
Stem Cells, September 1, 2000; 18(5): 320 - 330.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. M. ABRAHAM, A. GILL, A. AHMED, M. W. SIELCZAK, I. T. LAUREDO, Y. BOTINNIKOVA, K.-C. LIN, B. PEPINSKY, D. R. LEONE, R. R. LOBB, et al.
A Small-Molecule, Tight-binding Inhibitor of the Integrin alpha 4beta 1 Blocks Antigen-induced Airway Responses and Inflammation in Experimental Asthma in Sheep
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 603 - 611.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. M. ABRAHAM, A. AHMED, J. R. SABATER, I. T. LAUREDO, Y. BOTVINNIKOVA, R. J. BJERCKE, X. HU, B. M. REVELLE, T. P. KOGAN, I. L. SCOTT, et al.
Selectin Blockade Prevents Antigen-induced Late Bronchial Responses and Airway Hyperresponsiveness in Allergic Sheep
Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1205 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. HOJO, K. MAGHNI, T. B. ISSEKUTZ, and J. G. MARTIN
Involvement of alpha -4 Integrins in Allergic Airway Responses and Mast Cell Degranulation In Vivo
Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1127 - 1133.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. G. O'Riordan, Y. Mao, R. Otero, J. Lopez, J. R. Sabater, and W. M. Abraham
Budesonide affects allergic mucociliary dysfunction
J Appl Physiol, September 1, 1998; 85(3): 1086 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. L. Chen, A. Whitty, D. Scott, W.-C. Lee, M. Cornebise, S. P. Adams, R. C. Petter, R. R. Lobb, and R. B. Pepinsky
Evidence That Ligand and Metal Ion Binding to Integrin alpha 4beta 1 Are Regulated through a Coupled Equilibrium
J. Biol. Chem., September 21, 2001; 276(39): 36520 - 36529.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1997 American Thoracic Society 		  ATS Coding and Billing Quarterly